Jason Brandt, Ph.D.
Email Address: jbrandt@jhmi.edu
Dr. Brandt obtained his Ph.D. in experimental and physiological psychology from Boston University in 1982. Since that time, he has been on the faculty of the Johns Hopkins University, where he is currently Professor of Psychiatry and Behavioral Sciences, Professor of Neurology, and Director of the Division of Medical Psychology in the School of Medicine. He is also Director of the Cortical Function Laboratory at the Johns Hopkins Hospital, and is Research Director at the Copper Ridge Institute.
Dr. Brandt’s research focuses on the neuropsychology of memory and other cognitive disorders as they appear in Alzheimer’s disease, Huntington’s disease, and other dementia syndromes. He has also investigated the cognitive changes associated with epilepsy and its treatments, the psychological consequences of genetic testing for neuropsychiatric disorders, and improved methods for neuropsychological assessment. He has published over 250 articles and book chapters on these and related topics.
Dr. Brandt is a Fellow of both the American Psychological Association (APA) and the Association of Psychological Science (APS), and is board-certified by the American Board of Clinical Neuropsychology. He has served on the governing boards of the International Neuropsychological Society, the American Academy of Clinical Neuropsychology, and numerous editorial and professional advisory boards. Dr. Brandt served as President of both the APA’s Division of Clinical Neuropsychology (2000-2001) and the International Neuropsychological Society (2004-2005). He served on the Medical and Scientific Advisory Board of the Alzheimer’s Association from 1992 to 1994, and is currently on the editorial board of its journal, Alzheimer’s & Dementia.
Scarmeas N, Brandt J, Blacker D, Albert M, Hadjigeorgiou G, Dubois B, Devanand D, Honig L, Stern Y. Disruptive behavior as a predictor in Alzheimer’s disease. Arch Neurol 2007; 64: 1755-1761.
Stavitsky K, Brickman A, Scarmeas N, Torgan R, Tang M, Albert M, Brandt J, Blacker D, Stern Y. The progression of cognition, psychiatric symptoms and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2006; 63: 1450-1456.
Ward J, Sheppard J, Shpritz B, Margolis R, Rosenblatt A, Brandt J. A four-year prospective study of cognitive functioning in Huntington’s disease. J Int Neuropsychol Soc 2006; 12: 445-454.
Holtzer R, Irizarry M, Sanders J, Hyman B, Wegesin D, Riba A, Brandt J, Albert M, Stern Y. Relation of quantitative indexes of concurrent a-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease. Arch Neurol, 2006; 63: 226-230.
Sarazin M, Stern Y, Berr C, Albert M, Brandt J, Dubois B. Neuropsychological predictors of dependency in patients with Alzheimer’s disease. Neurol 2005; 64: 1027-1031.
Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer’s disease. Arch Neurol, 2005; 62; 1601-1608.
|